Bangkok, BKGI opened its first day of trading at 2.18 baht, an increase of 0.55 baht or 33.74% from the IPO price of 1.63 baht.
Bangkok Genomics Innovation Public Company Limited (BKGI) is listed and begins trading on the Stock Exchange. in the service industry group Medical business category today, with a security value at the IPO price of 978 million baht, using the securities trading abbreviation BKGI, opened for trading at 2.18 baht, an increase of 0.55 baht or 33.74% from the IPO price of 1.63 baht.
BKGI is a provider of medical diagnosis using genetic technology. world class modern The main service is the examination and screening of chromosomal abnormalities in the fetus from the mother’s blood. (Non-Invasive Prenatal Testing : NIPT) under the brand ‘NIFTY’ that has gained wide popularity. Screening for carriers of genetic diseases and cancer with advanced technology
Trinity Securities (as the distributor and underwriter for the sale of BKGI’s newly issued ordinary shares this time) estimates the 2
024 target price of BKGI at 2.65 baht using the P/E Ratio method at 30 times, which is a PER level. of SET Healthcare currently has an EPS forecast for 2024 at 0.09 baht per share, while the profit trend in 2024-2025, Analysis Department Estimated at 53 million baht and 77 million baht, profits grew 65.24% and 44.36% respectively, increasing as service and sales income increased, especially the growth in income from abnormality screening. way Increasing genetics in reproductive health. The company will expand to major cities in the region where access rates are still low.
Company’s business Involved with Bio Technology in DNA level analysis which leads to new medical treatment processes which is a Mega Trend at present, BGI Group, whose major shareholder has knowledge Expertise and is a leader in technology about genomes at the international level The trend of net profit growth in 2024-2025 is considered to be an average growth rate (CAGR) of 55% per year.
Source: Thai News Agency